期刊文献+

乙酰水杨酸姜黄素酯对血管紧张素Ⅱ诱导的血管平滑肌细胞增殖的影响及相关机制 被引量:5

Effect and Mechanism of Curcumin Acetylsalicylate on Angiotensin Ⅱ Induced Proliferation in Vascular Smooth Muscle Cells
下载PDF
导出
摘要 目的探讨乙酰水杨酸姜黄素酯(curcumin acetylsalicylate,CA)对血管紧张素Ⅱ(Angiotensin Ⅱ,Ang Ⅱ)诱导的血管平滑肌细胞(vascular smooth muscle cells,VSMC)增殖的抑制作用及其相关机制。方法建立Ang Ⅱ诱导的VSMC增殖模型。采用MTT法、流式细胞术观察CA干预对细胞活力和周期的影响。Western blot检测其对第10号染色体同源缺失性磷酸酶张力蛋白(phosphatase and tensin homolog deleted on chromosome ten,PTEN)、磷酸化AKT(p-AKT)、AKT蛋白表达的影响。结果 1、3、10μmol/L CA可以显著抑制Ang Ⅱ诱导的细胞活力,其中3μmol/L为最佳浓度(P<0.05)。在CA的干预下,与Ang Ⅱ组比较,流式细胞术显示VSMC G0/G1期细胞数量明显增加,S期明显减少;Western blot显示其可以促进PTEN蛋白表达,从而抑制AKT激活(P<0.05)。结论 CA可以抑制Ang Ⅱ诱导的VSMC增殖,其机制与阻滞VSMC G0/G1期向S期转化,以及调节PTEN/AKT信号通路有关。 Objective To investigate the effect and mechanism of curcumin acetylsalicylate(CA) on Angiotensin Ⅱ(Ang Ⅱ) induced proliferation in vascular smooth muscle cells(VSMC).Methods VSMC proliferation model was induced by Ang Ⅱ.Flow cytometry was used to observe the effect of CA on cell proliferation and cycle.The expressions of PTEN,p-AKT and AKT was detected by Western blot.Results 1,3,10 μmol/L CA led to a significant inhibition of Ang Ⅱ-induced proliferation of VSMCs and 3 μmol/L CA was proved to be an optimal inhibitory concentration(P 0.05).Flow cytometry showed that the number of cells in G0/G1 phase increased significantly and the number of S phase decreased significantly by the intervention of CA.Western blot showed that it could promote the expression of PTEN protein and inhibit the activation of AKT(P〈0.05).Conclusion CA can obviously inhibit the VSMC proliferation induced by Ang Ⅱ,and its mechanism is related to the inhibition of transformation from G0/G1 phase to S phase and the regulation of PTEN/Akt signaling pathway.
作者 孙四玉 杨冬梅 戴娜 夏伯候 庹勤慧 SUN Siyu;YANG Dongmei;DAI Na;XIA Bohou;TUO Qinhui(School of Pharmacy, Hunan University of Chinese Medicine, Changsho, Hunan 410208, China;Medical School, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China)
出处 《湖南中医药大学学报》 CAS 2017年第11期1222-1225,共4页 Journal of Hunan University of Chinese Medicine
基金 国家自然科学基金项目(81673722) 湖南省杰出青年基金(14JJ1024) 省自然科学基金(2015JJ2117) 湖南省教育厅重点项目(16A156)
关键词 乙酰水杨酸姜黄素酯 血管紧张素Ⅱ 血管平滑肌细胞增殖 PTEN AKT curcumin acetylsalicylate angiotensin II vascular smooth muscle cells proliferation PTEN AKT
  • 相关文献

参考文献4

二级参考文献40

  • 1刘剑敏,姜凤超.抗肿瘤前药-姜黄素衍生物的设计合成及初步活性测试[J].中国药师,2005,8(7):543-545. 被引量:18
  • 2Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). J Vasc Surg,2000,31 : S1-296.
  • 3Schillinger M, Exner M, Mlekusch W, et al. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts. J Endovasc Ther,2003,10:557-565.
  • 4Johnston KW. Femoral and popliteal arteries : reanalysis of results of balloon angioplasty. Radiology, 1992,183:767-771.
  • 5Minar E, Pokrajac B, Maca T, et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study. Circulation, 2000, 102 : 2694- 2699.
  • 6Koppensteiner R, Spring S,Amann-Vesti BR, et al. Low-molecular- weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial. J Vasc Surg,2006,44 : 1247-1253.
  • 7Leon MB, Bairn DS, Popma JJ, et al. A clinical trial comparing three antithrombotie-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med, 1998,339 : 1665-1671.
  • 8Bertrand ME,Legrand V, Boland J,et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine ( fantastic ) study. Circulation. 1998.98:1597-1603.
  • 9Rubboli A, Milandri M, Castelvetri C,et al. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting. Cardiology ,2005,104 : 101-106.
  • 10Rothberg MB, Celestin C, Fiore LD, et al. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta- analysis with estimates of risk and benefit. Ann Intern Med ,2005, 143 : 241-250.

共引文献18

同被引文献43

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部